Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 12:22 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1321–1344 of 1,387 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Intervention Effectiveness Clear all

Conditions: All Conditions of Integrative Medicine Clinic Patients
Interventions: Not listed
Lead sponsor: BraveNet; Other
Eligibility: 18 Years and older
Enrollment: 5,069 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2019
U.S. locations: 14
States / cities: La Jolla, California • San Francisco, California • Santa Monica, California + 11 more

Conditions: Myeloid Malignancy
Interventions: CHORDS; Other
Lead sponsor: University of Rochester; Other
Eligibility: 21 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Autism Spectrum Disorder
Interventions: Pathways Intervention, Parent Education Intervention (PEI); Behavioral
Lead sponsor: The University of Texas at Dallas; Other
Eligibility: 12 Months to 42 Months
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Breast Cancer, Adjuvant Treatment, Early Stage Breast Cancer
Interventions: Switch, Guideline Directed Intervention (GDI); Drug · Other
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Self-Management, Quality of Life
Interventions: Strong Together serious game, Enhanced Care as Usual; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older · Female only
Enrollment: 344 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Hypothalamic Obesity, Hypothalamic Tumor, Craniopharyngioma
Interventions: Phentermine / Topiramate Extended Release Oral Capsule [Qsymia], Placebo; Drug · Other
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 6 Years to 28 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania • Seattle, Washington

Conditions: Primary Biliary Cholangitis
Interventions: Not listed
Lead sponsor: Ipsen; Industry
Eligibility: Not listed
Enrollment: 424 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2032
U.S. locations: 19
States / cities: Coronado, California • Los Angeles, California • Sacramento, California + 15 more

Conditions: Adolescent Behavior
Interventions: Sexual Health, Alcohol Prevention, Teen Driving; Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 14 Years to 17 Years
Enrollment: 348 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Cardiac Disease, Coronary Artery Disease
Interventions: CELT ACD; Device
Lead sponsor: Vasorum Ltd; Industry
Eligibility: 18 Years and older
Enrollment: 241 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 2
States / cities: Camden, New Jersey • New York, New York

Conditions: Asthma
Interventions: Not listed
Lead sponsor: Meharry Medical College; Other
Eligibility: 18 Years and older
Enrollment: 62 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Typical Preschoolers Who Can Not Zipper
Interventions: Standard zippering vest, Modified zippering vest; Behavioral
Lead sponsor: Salus University; Other
Eligibility: 42 Months to 60 Months
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Jenkintown, Pennsylvania

Conditions: Overweight, Obesity, Weight Loss, Health Behavior, Lifestyle Intervention
Interventions: Simplified Dietary Self-Monitoring, Detailed Dietary Self-Monitoring, Core Behavioral Weight Loss Intervention; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 328 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Hypochondroplasia
Interventions: Vosoritide, Placebo; Drug
Lead sponsor: BioMarin Pharmaceutical; Industry
Eligibility: 3 Years to 17 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 4
States / cities: Wilmington, Delaware • Washington D.C., District of Columbia • Chicago, Illinois + 1 more

Conditions: Anesthesia
Interventions: Tetracaine HCl 3% and Oxymetazoline HCl 0.05%, Placebo; Drug
Lead sponsor: St. Renatus, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 3
States / cities: Loma Linda, California • Baltimore, Maryland • Philadelphia, Pennsylvania

Conditions: Migraine Disorders
Interventions: sumatriptan succinate/naproxen sodium, placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 320 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 34
States / cities: Mesa, Arizona • Little Rock, Arkansas • Fair Oaks, California + 31 more

Conditions: Hypertension, Cognitive Decline
Interventions: Stepped-care protocol adapted from the SPRINT intensive-treatment algorithm; Behavioral
Lead sponsor: Tulane University; Other
Eligibility: 40 Years and older
Enrollment: 1,306 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Depression, Anxiety, Mental Health Issue, Mental Health Wellness 2
Interventions: BetterHelp; Other
Lead sponsor: Teladoc Health; Industry
Eligibility: 18 Years and older
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: San Jose, California

Conditions: Postoperative Nausea and Vomiting, Nausea and Vomiting, Postoperative
Interventions: GW597599; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 624 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 17
States / cities: Little Rock, Arkansas • Glendale, California • Laguna Hills, California + 13 more

Conditions: Temporomandibular Disorder (TMD)
Interventions: SPM Precursor-Enriched Marine Lipid Supplement, Medium-Chain Triglyceride Supplement; Dietary Supplement
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Post-Concussion Syndrome, Post-Traumatic Headache, Post-Concussive Syndrome, Chronic, Head Injury, MTBI - Mild Traumatic Brain Injury, Acquired Brain Injury, Closed Head Injury
Interventions: Exercise+CT, Exercise only; Behavioral
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Migraine, Migraine Disorders
Interventions: sumatriptan succinate/naproxen sodium; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 351 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 35
States / cities: Chandler, Arizona • Irvine, California • Redondo Beach, California + 30 more

Conditions: Amyotrophic Lateral Sclerosis
Interventions: Placebo (for MN-166), MN-166, riluzole; Drug
Lead sponsor: MediciNova; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Nicotine Dependence
Interventions: Integrated Training for Smokers, Mindfulness Training for Smokers, Quitline; Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Motor Coordination or Function; Developmental Disorder
Interventions: OT-SI; Other
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 59 Months to 107 Months
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Richmond, Virginia

Search by objective public record fields.

Registry for Integrative Medicine Interventions Effectiveness

Considering alloHCT: Opportunities for Patient Reflection During Decision-Making Via Digital Stories

Evaluating the Efficacy of Pathways Parent-Mediated Early Autism Intervention on Social Attention and Language

Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients

Efficacy of a Self-advocacy Serious Game Intervention

Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity

A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment

The P4 Intervention Study to Improve Adolescent Health

Clinical Investigation for Safety and Efficacy Study of CELT ACD (Arterial ClosureDevice)

Developing Asthma Interventions Using Community Based Research

Efficacy of an Intervention to Teach Zippering: A Two-Group Control Study

Simplifying Diet Tracking in a Digital Weight Loss Intervention

Interventional Study of Vosoritide for the Treatment of Children With Hypochondroplasia

Comparison of Intranasal Kovacaine Mist, and Placebo for Anesthetizing Maxillary Teeth in Adults

Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea

Implementation of Multifaceted Patient-Centered Treatment Strategies for Intensive Blood Pressure Control in Minimize Cognitive Decline

Clinical Outcomes of a Digital Mental Health Intervention for Moderate/Severe Depression and Anxiety

Study Of An NK-1 Anti-Emetic Medication For The Prevention Of Post-Operative Nausea And Vomiting In Female Patients

Marine Lipids Ease Painful TMD

Aerobic Exercise and Cognitive Training Effects on Postconcussive Symptomology

Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA)

Ibudilast (MN-166) in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Study Two on the Effectiveness of Mindfulness Training for Smokers

A Multiple Baseline Design Study to Investigate the Effectiveness of OT-SI Using an Intensive Intervention Model